iBio (IBIO) Net Equity Issued and Repurchased (2009 - 2026)
iBio (IBIO) recorded Net Equity Issued and Repurchased of -$5.94 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $2.41 million a year earlier.
Powered by 
Analysis
iBio (IBIO) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio reported Net Equity Issued and Repurchased of $72.68 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 322.5% (FY2021 to FY2026).
- Across earlier fiscal years, Net Equity Issued and Repurchased came in at $3.54 million in FY2025 (-86.1%), $25.52 million in FY2024 (+122.2%), $11.49 million in FY2023 and $77,000 in FY2022 (+42.6%).
- The fiscal Q4 2026 figure is the lowest quarterly Net Equity Issued and Repurchased in data going back to fiscal Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | 8,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8,000.00 |
| Jun 30, 2026 | -12.32 Mn |
| Mar 31, 2026 | 44.01 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 14.32 Mn |
| Mar 31, 2024 | 4.28 Mn |
| Dec 31, 2023 | 4.12 Mn |
| Sep 30, 2023 | 2.81 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Dec 31, 2021 | 77,000.00 |
| Jun 30, 2021 | 3.02 Mn |
| Mar 31, 2021 | 33.86 Mn |
| Dec 31, 2020 | 38.28 Mn |
API Access
iBio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();